Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
D000230:Adenocarcinoma / Q000097:blood; D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology*; D001797:Blood Protein Electrophoresis; D001984:Bronchial Neoplasms / Q000097:blood; D002277:Carcinoma / Q000097:blood; D002283:Carcinoma, Bronchogenic / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000097:blood; D002294:Carcinoma, Squamous Cell / Q000097:blood; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000097:blood*; D008259:Macroglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000510:Alpha-Globulins; D008259:Macroglobulins; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D005341:Fibrinolysin